Retrospective practice review of treatment of metastatic non-small-cell lung cancer with second-line erlotinib

BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitors (egfr-tkis) and chemotherapy have both demonstrated efficacy in recurrent metastatic non-small-cell lung cancer (nsclc) following failure of first-line platinum-based chemotherapy. Although the 3 available therapeutic agents—doc...

Descripción completa

Detalles Bibliográficos
Autores principales: Melosky, B., Agulnik, J., Assi, H.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2008
Materias:
Medical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2601023/
https://www.ncbi.nlm.nih.gov/pubmed/19079629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2601023/
https://www.ncbi.nlm.nih.gov/pubmed/19079629

Ejemplares similares